The treatment of moderate to severe IBD with anti-TNF biologics and immunomodulators

preview_player
Показать описание
In this presentation from the Clinical Track at the 2017 Advances in Inflammatory Bowel Diseases conference, Dr. Gary R. Lichtenstein discusses the treatment of moderate to sever IBD with anti-TNF biologics and immunomodulators.

Earn CME credit for this activity at the following location:

© 2017 Imedex, LLC.
Рекомендации по теме